Mizoribine provides effective treatment of sequential histological change of arteritis and reduction of inflammatory cytokines and chemokines in an animal model of Kawasaki disease

BACKGROUND: Intravenous immunoglobulin (IVIg) treatment results in an effective response from patients with acute-phase Kawasaki disease (KD), but 16.5% of them remain nonresponsive to IVIg. To address this therapeutic challenge, we tried a new therapeutic drug, mizoribine (MZR), in a mouse model of...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Takahashi, Kei, Oharaseki, Toshiaki, Nagao, Tomokazu, Yokouchi, Yuki, Yamada, Hitomi, Nagi-Miura, Noriko, Ohno, Naohito, Saji, Tsutomu, Okazaki, Tomio, Suzuki, Kazuo
格式: Artigo
語言:Inglês
出版: BioMed Central 2011
主題:
Short Report
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3239324/
https://ncbi.nlm.nih.gov/pubmed/21958311
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1546-0096-9-30
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍